Purification and properties of heparin-releasable lipoprotein- associated coagulation inhibitor

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1955 • 8,846 citations

Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

1977 • 791 citations

The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

1988 • 482 citations

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

1989 • 475 citations

Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides.

1987 • 431 citations

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

1988 • 401 citations

Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

1988 • 331 citations

Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

1990 • 271 citations

Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples

1991 • 239 citations

Heparin-induced release of extracellular superoxide dismutase to human blood plasma

1987 • 222 citations

Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor

1977 • 216 citations

Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor

1988 • 212 citations

Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma

1989 • 204 citations

Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation

1987 • 200 citations

Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent

1986 • 124 citations

Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.

1990 • 114 citations

Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor : Evidence that endothelium is the principal site of its synthesis

1990 • 102 citations

Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease.

1987 • 80 citations

Lipoprotein lipase uptake by the liver: localization, turnover, and metabolic role

1988 • 68 citations

Heparin‐induced Diamine Oxidase Increase in Human Blood Plasma

1966 • 57 citations

Effect of heparin on the in vivo release and clearance of human platelet factor 4

1983 • 57 citations

Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): Chemical and biological consequences

1982 • 52 citations

THE SITES AT WHICH PLASMA CLEARING ACTIVITY IS PRODUCED AND DESTROYED IN THE RAT

1954 • 47 citations

Characterization of apolipoprotein E-containing lipoproteins

1986 • 41 citations

Isolation of the lipoprotein associated coagulation inhibitor produced by HepG2 (human hepatoma) cells using bovine factor Xa affinity chromatography

1987 • 32 citations

Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2

1990 • 28 citations

Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: No evidence for clinical benefit of heparinization during the initial phase of treatment

1989 • 23 citations

Purification of canine post-heparin hepatic lipase

1982 • 17 citations